Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Novartis”
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
Germany
Sponsor: Nationwide Children's Hospital
High Grade Glioma · Diffuse Intrinsic Pontine Glioma · Anaplastic Astrocytoma · Glioblastoma
United States, Australia, Canada, Germany, New Zealand +1 more
- Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in FranceActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Chronic Myeloid Leukemia
France
- Inclisiran Effectiveness in China: a Pragmatic Randomized TrialActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Coronary Heart Disease
China
- A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) ElevationActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Relapsing-Remitting Multiple Sclerosis
United States, Canada
Sponsor: Sarit Assouline
Chronic Myeloid Leukemia · Chronic Myeloid Leukemia, BCR/ABL-Positive · Chronic Myeloid Leukemia in Remission
Canada
Sponsor: Melanoma Institute Australia
Melanoma
Australia
Sponsor: University of Southern California
Colon Cancer · Colorectal Cancer
United States
Sponsor: Novartis Pharmaceuticals
Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD)
France, Germany, Singapore, Spain
Sponsor: Novartis Pharmaceuticals
Fascioliasis
Colombia, Egypt, Peru, Turkey (Türkiye), Vietnam
Sponsor: Novartis Pharmaceuticals
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
United States, Argentina, Bulgaria, Canada, Czechia +19 more
Sponsor: Novartis Pharmaceuticals
Prostate Cancer
United States, Australia, Brazil, China, Hong Kong +7 more
- Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MSActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
United States, Argentina, Australia, Austria, Belgium +32 more
Sponsor: Yale University
HER2 Negative Breast Cancer
United States
Sponsor: UNICANCER
Breast Cancer
France, Germany, Italy, Netherlands, Spain
Sponsor: National Cancer Centre, Singapore
Metastatic Nasopharyngeal Cancer
Singapore
- SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)Active Not Recruiting
Sponsor: Borstkanker Onderzoek Groep
Neoplasm, Breast · Congenital, Familial and Genetic Disorders
Netherlands
Sponsor: M.D. Anderson Cancer Center
Chronic Myelomonocytic Leukemia · Myelodysplastic Syndrome · Recurrent Chronic Myelomonocytic Leukemia · Recurrent Myelodysplastic Syndrome
United States
- Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary SyndromeActive Not Recruiting
Sponsor: Washington University School of Medicine
Mycosis Fungoides · Sezary Syndrome · Mycosis Fungoides/Sezary Syndrome
United States
- Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPARecruiting
Sponsor: Novartis Pharmaceuticals
ANCA Associated Vasculitis (AAV)
United States, Brazil, Israel, Japan, Saudi Arabia +3 more
Sponsor: Novartis Pharmaceuticals
Metastatic Pancreatic Ductal Adenocarcinoma
United States, Australia, Belgium, Brazil, Canada +22 more
Sponsor: Novartis Pharmaceuticals
Active Secondary Progressive Multiple Sclerosis
Italy
- Ilaris NIS in KoreaRecruiting
Sponsor: Novartis Pharmaceuticals
Hereditary Periodic Fever Syndromes · Cryopyrin-associated Periodic Syndromes (CAPS) · Colchicine Resistance Familial Mediterranean Fever (crFMF) · TNF Receptor Associated Periodic Syndrome (TRAPS)
South Korea
Sponsor: Novartis Pharmaceuticals
Major Depressive Disorder With Suicidal Ideation With Intent
United States, Argentina, Brazil, Canada, Germany +9 more
Sponsor: Novartis Pharmaceuticals
Sjögren Syndrome
United States, Argentina, Australia, Austria, Brazil +18 more